DANIEL PIETRAS: Open Payments
NPI 1912346123 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 52 payments from 12 companies in 2025. Trend: 2023 $261 · 2024 $0 · 2025 $1,539
Food & beverage: $1,466Travel & lodging: $72
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $326 |
| E.R. Squibb & Sons, L.L.C. | 2 | $194 |
| Janssen Pharmaceuticals, Inc | 8 | $183 |
| Axsome Therapeutics, Inc. | 4 | $168 |
| Neurocrine BioSciences, Inc. | 3 | $166 |
| Alkermes, Inc. | 9 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| ABBVIE INC. | 3 | $64 |
Products named: AUSTEDO XR, Auvelity, INGREZZA, ARISTADA, COBENFY, UZEDY, SPRAVATO, REXULTI.
Industry payments across FL — which companies pay providers there.
